C. Kessler

Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.

Hans H. Jung, A. Cavalli, L. Mazzucchelli, 2020, Swiss medical weekly.

Management of transthyretin amyloidosis.

L. Mazzucchelli, R. Manka, A. Pazhenkottil, 2021, Swiss medical weekly.

Management of transthyretin amyloidosis.

L. Mazzucchelli, R. Manka, A. Pazhenkottil, 2021, Swiss medical weekly.

Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis

D. Rossi, G. Colucci, L. Elzi, 2020, Journal of Thrombosis and Thrombolysis.

Unresectable pancreatic cancer: what is the optimal procedure?

C. Kessler, D. Morris, D. Mosdell, 1991, Southern medical journal.

Multiple arterial and venous thromboemboli in a man with chronic myelogenous leukemia and occult metastatic breast carcinoma: the significance of thrombocythemia.

K. C. Anderson, H. Klein, C. Kessler, 1982, Southern medical journal.

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

N. Kucher, G. Colucci, M. Schindewolf, 2022, The Lancet Haematology.

Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis.

C. Gobbi, G. Melli, G. Stussi, 2023, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.